Eurocastle Investment Limited
Contact:
Oak Fund Services (Guernsey) Limited
Company Administrator
Attn: Mark Woodall
Tel: +44 1481 723450
Change of Home State Regulator
Guernsey, 15 January 2021 - Eurocastle Investment Limited has applied to change its home state regulator from the United Kingdom (“UK”) FCA to the Netherlands AFM as a result of the UK having left the European Union as at 31 December 2020.
ADDITIONAL INFORMATION
For investment portfolio information, please refer to the Company’s most recent Financial Report, which is available on the Company’s website (www.eurocastleinv.com ).
ABOUT EUROCASTLE
Eurocastle Investment Limited (“Eurocastle” or the “Company”) is a publicly traded closed-ended investment company, focused on Italian performing and non-performing loans, Italian loan servicing platforms and other real estate related assets in Italy. On 18 November 2019, the Company announced a plan to realise the majority of its assets with the aim of accelerating the return of value to shareholders. The Company will not currently seek material new investments from the proceeds of the realisation but, will continue to support its existing investments to the extent required in order to optimise returns and distribute cash to shareholders when available (the “Realisation Plan”). For more information regarding Eurocastle Investment Limited and to be added to our email distribution list, please visit www.eurocastleinv.com .
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Santhera Pharmaceuticals Holding AG8.1.2026 08:16:03 CET | Press release
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
CMR Surgical8.1.2026 08:03:26 CET | Press release
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
Sampo plc8.1.2026 07:30:00 CET | Press release
Sampo plc’s share buybacks 7 January 2026
Basilea Pharmaceutica AG, Allschwil8.1.2026 07:15:00 CET | Press release
Basilea provides portfolio update and outlook
Sodexo SA8.1.2026 07:00:00 CET | Press release
Sodexo Q1 Fiscal 2026 revenues in line with expectations
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
